UBS Group set a €53.00 ($63.10) price target on Brenntag (FRA:BNR) in a report published on Monday, www.boersen-zeitung.de reports. The firm currently has a neutral rating on the stock.
BNR has been the topic of several other reports. Credit Suisse Group set a €47.00 ($55.95) price target on shares of Brenntag and gave the company a sell rating in a research note on Wednesday, January 3rd. Kepler Capital Markets set a €57.00 ($67.86) price objective on Brenntag and gave the company a buy rating in a report on Tuesday, November 28th. Jefferies Group set a €61.00 ($72.62) price objective on Brenntag and gave the company a buy rating in a report on Wednesday, January 3rd. Baader Bank set a €62.00 ($73.81) price objective on Brenntag and gave the company a buy rating in a report on Monday, December 18th. Finally, Deutsche Bank set a €56.00 ($66.67) price objective on Brenntag and gave the company a buy rating in a report on Thursday, November 9th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and ten have issued a buy rating to the stock. The stock has an average rating of Buy and an average price target of €56.50 ($67.26).
Shares of Brenntag (BNR) traded up €1.24 ($1.48) during trading on Monday, reaching €54.84 ($65.29). 338,319 shares of the company’s stock traded hands. The stock has a market capitalization of $8,520.00 and a price-to-earnings ratio of 21.17. Brenntag has a one year low of €43.06 ($51.26) and a one year high of €56.25 ($66.96).
Brenntag Company Profile
Brenntag AG, a chemical distribution company, provides distribution solutions for industrial and specialty chemicals worldwide. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.